The problem was Marie should probably have never been lifted to CEO from CMO she was in her niche with the previous role but kind of the same problem with a lot bio's when they try to cross the business with science. You need strong business minds to steer company direction & strong medical to steer the science - if you don't have that it's only ever coming from weaker foundations.
She was very good for the science though when you look at her background against PAB's lead candidate.
CEO Resigns, page-25
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1031794 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1050244 | 4 |
View Market Depth
| Last trade - 10.06am 22/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable